Science Explorer Back to mapMap
Discussion
Researcher · Cornell University · United States

David C. Lyden

David C. Lyden publishes mostly in Molecular Biology, Oncology and Cancer Research, on topics such as Extracellular vesicles in disease, Cancer Cells and Metastasis and MicroRNA in disease regulation.

ORCID 0000-0003-0193-4131 OpenAlex
World rank
#14,836
of 7,710,434 ranked researchers
Rank in United States
#5,244
of 1,627,098
Works
312
Citations
55k
Citations per work
176.8
h-index
76
i10-index 138Top 0.8% in Molecular Biology
David C. Lyden

What does David C. Lyden research?

David C. Lyden's work is mostly in Biochemistry, Genetics and Molecular Biology (38%), Medicine (24%), Immunology and Microbiology (6%).

Life Sciences: 139 works · 44.4% of their workBiochemistry, Genetics and Molecular Biology: 118 works · 37.9% of their workMolecular Biology: 83 works · 26.5% of their workCancer Research: 36 works · 11.4% of their workImmunology and Microbiology: 20 works · 6.5% of their workImmunology: 20 works · 6.5% of their workEverything else: 98 works · 31.3% of their workHealth Sciences: 76 works · 24.3% of their workMedicine: 76 works · 24.3% of their workOncology: 43 works · 13.9% of their workGenetics: 16 works · 5.2% of their workPulmonary and Respiratory Medicine: 16 works · 5.2% of their workTHEIR WORKDavid C. Lyden312works
Life Sciences44%Health Sciences24%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology11837.9%
    2. Immunology and Microbiology206.5%
  2. Everything else9831.3%
    1. Medicine7624.3%
  1. 1Molecular Biology26% of their works
  2. 2Oncology14% of their works
  3. 3Cancer Research11% of their works
  4. 4Immunology6% of their works
  5. 5Pulmonary and Respiratory Medicine5% of their works
  6. 6Genetics5% of their works

Research topics

Which keywords describe David C. Lyden's research?

The keywords of their largest research topics: Cancer, Biogenesis, Biomarkers, Exosomes, Extracellular Vesicles, Cancer Stem Cells, Tumor Metastasis and Gene Expression.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Cancer1183 topics
  2. Biogenesis1042 topics
  3. Biomarkers1042 topics
  4. Exosomes731 topic
  5. Extracellular Vesicles731 topic
  6. Cancer Stem Cells351 topic
  7. Tumor Metastasis351 topic
  8. Gene Expression311 topic
  9. MicroRNA311 topic
  10. VEGF301 topic
  11. endothelial progenitor cells301 topic
  12. Glioblastoma211 topic
  13. HIF-1211 topic
  14. Temozolomide211 topic
  15. Warburg Effect211 topic
  16. Activation141 topic
  17. Macrophage141 topic
  18. Cancer Genomics131 topic
  19. Mutational Signatures131 topic

Where does David C. Lyden work?

David C. Lyden's main affiliation in the publication record is Cornell University, United States.

How many publications and citations does David C. Lyden have?

OpenAlex counts 312 works and 55,151 citations for David C. Lyden, an h-index of 76, ranking #14,836 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about David C. Lyden. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.